Clinical Trial

Time Restricted Eating (TRE) in Bipolar Disorder

Study acronym: TREBD
Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized controlled trial investigating the effects of an 8-TRE intervention compared to a wait list (control) on metabolic health and body composition in people diagnosed with BD and who are currently obese and at least mildly depressed. Following a 1-week baseline assessment, participants will be randomized to either a TRE or the wait list (1-to-1 ratio) for 8 weeks. At baseline, Week 8 (post treatment), and Week 20 (follow-up), investigators will assess daily eating patterns for one week, followed by collection of fasting lipids, body weight and vital signs. At Week 4 (i.e., mid-treatment), the investigators will assess self-reported outcomes only. Participants assigned to the wait list condition will have the option of receiving the TRE intervention after 20 weeks.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-16
Trial Details
NCT Number NCT07211217
Lead Sponsor Massachusetts General Hospital
Collaborators: Brigham and Women's Hospital
Conditions Bipolar Disorder (BD), Bipolar Disorder Depression, Overweight (BMI > 30)
Enrollment 40 participants
Start Date 2026-06-15
Primary Completion 2026-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-15